HK1041686B - N-芳基磺酰氨基酸ω-酰胺 - Google Patents
N-芳基磺酰氨基酸ω-酰胺 Download PDFInfo
- Publication number
- HK1041686B HK1041686B HK02103391.7A HK02103391A HK1041686B HK 1041686 B HK1041686 B HK 1041686B HK 02103391 A HK02103391 A HK 02103391A HK 1041686 B HK1041686 B HK 1041686B
- Authority
- HK
- Hong Kong
- Prior art keywords
- formula
- alkyl
- hydrogen atom
- sulfonylamino
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19851184A DE19851184A1 (de) | 1998-11-06 | 1998-11-06 | N-Arylsulfonyl-aminosäure-omega-amide |
| DE19851184.1 | 1998-11-06 | ||
| PCT/EP1999/007979 WO2000027808A1 (de) | 1998-11-06 | 1999-10-21 | N-arylsulfonyl-aminosäure-omega-amide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1041686A1 HK1041686A1 (en) | 2002-07-19 |
| HK1041686B true HK1041686B (zh) | 2005-09-23 |
Family
ID=7886902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK02103391.7A HK1041686B (zh) | 1998-11-06 | 1999-10-21 | N-芳基磺酰氨基酸ω-酰胺 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6201130B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1124797B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4348014B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100655632B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1206213C (cg-RX-API-DMAC7.html) |
| AR (1) | AR021086A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE260889T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU757602B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR9915729A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2350031C (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ302291B6 (cg-RX-API-DMAC7.html) |
| DE (2) | DE19851184A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1124797T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2213405T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1041686B (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0104122A3 (cg-RX-API-DMAC7.html) |
| ID (1) | ID28810A (cg-RX-API-DMAC7.html) |
| PL (1) | PL198827B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1124797E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2228330C2 (cg-RX-API-DMAC7.html) |
| TR (1) | TR200101245T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000027808A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200103485B (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003042190A1 (en) | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
| US7071223B1 (en) * | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| PA8591801A1 (es) | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
| MXPA05010165A (es) * | 2003-04-15 | 2005-11-16 | Warner Lambert Co | Derivados de prolina biciclicos [c]-condensados y su uso para el tratamiento de estados artriticos. |
| EP1626962B1 (en) * | 2003-05-12 | 2007-02-28 | Pfizer Products Inc. | Benzamide inhibitors of the p2x7 receptor |
| CN1980902A (zh) * | 2004-06-29 | 2007-06-13 | 辉瑞产品有限公司 | 通过对羟基保护前体去保护而制备5-4-(2-羟基-丙基)-3,5-二氧代-4,5-二氢-3h-[1,2,4]三嗪-2-基-苯甲酰胺衍生物的方法 |
| CA2572118A1 (en) * | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| BRPI0512915A (pt) * | 2004-06-29 | 2008-04-15 | Warner Lambert Co | terapias de combinação utilizando inibidores benzamida do receptor p2x7 |
| US7576222B2 (en) | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
| MY144590A (en) | 2005-07-11 | 2011-10-14 | Wyeth Corp | Glutamate aggrecanase inhibitors |
| KR20080058436A (ko) | 2005-10-13 | 2008-06-25 | 와이어쓰 | 글루탐산 유도체의 제조 방법 |
| WO2012004743A1 (en) | 2010-07-09 | 2012-01-12 | Pfizer Limited | Benzenesulfonamides useful as sodium channel inhibitors |
| EP2953932B1 (en) * | 2013-02-06 | 2017-03-01 | Merck Patent GmbH | Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1063026A1 (ru) * | 1982-05-19 | 1990-12-07 | Институт биохимии АН ЛитССР | N @ -Бензолсульфонильные производные трес-DL-фенилсерина, обладающие противовоспалительной активностью |
| JP2764262B2 (ja) | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
| TW201303B (cg-RX-API-DMAC7.html) | 1990-07-05 | 1993-03-01 | Hoffmann La Roche | |
| US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| AU690703B2 (en) | 1994-06-22 | 1998-04-30 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
| US5863949A (en) * | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| EP0837901A1 (en) * | 1995-06-28 | 1998-04-29 | E.I. Du Pont De Nemours And Company | Fluoropolymer nanocomposites |
| KR980009238A (ko) | 1995-07-28 | 1998-04-30 | 우에노 도시오 | 설포닐아미노산 유도체 |
| CZ294063B6 (cs) * | 1996-05-17 | 2004-09-15 | Warner-Lambert Company | Bifenylsulfonamid, jeho použití a farmaceutický prostředek s jeho obsahem |
| DE19719621A1 (de) * | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarbonsäuren |
-
1998
- 1998-11-06 DE DE19851184A patent/DE19851184A1/de not_active Withdrawn
-
1999
- 1999-10-21 AT AT99971799T patent/ATE260889T1/de active
- 1999-10-21 DK DK99971799T patent/DK1124797T3/da active
- 1999-10-21 CN CNB998129321A patent/CN1206213C/zh not_active Expired - Fee Related
- 1999-10-21 ID IDW00200100995A patent/ID28810A/id unknown
- 1999-10-21 RU RU2001115706/04A patent/RU2228330C2/ru not_active IP Right Cessation
- 1999-10-21 CA CA2350031A patent/CA2350031C/en not_active Expired - Fee Related
- 1999-10-21 PT PT99971799T patent/PT1124797E/pt unknown
- 1999-10-21 JP JP2000580988A patent/JP4348014B2/ja not_active Expired - Fee Related
- 1999-10-21 HU HU0104122A patent/HUP0104122A3/hu unknown
- 1999-10-21 HK HK02103391.7A patent/HK1041686B/zh not_active IP Right Cessation
- 1999-10-21 DE DE59908769T patent/DE59908769D1/de not_active Expired - Lifetime
- 1999-10-21 WO PCT/EP1999/007979 patent/WO2000027808A1/de not_active Ceased
- 1999-10-21 ES ES99971799T patent/ES2213405T3/es not_active Expired - Lifetime
- 1999-10-21 TR TR2001/01245T patent/TR200101245T2/xx unknown
- 1999-10-21 EP EP99971799A patent/EP1124797B1/de not_active Expired - Lifetime
- 1999-10-21 BR BR9915729-2A patent/BR9915729A/pt not_active Application Discontinuation
- 1999-10-21 CZ CZ20011506A patent/CZ302291B6/cs not_active IP Right Cessation
- 1999-10-21 KR KR1020017005590A patent/KR100655632B1/ko not_active Expired - Fee Related
- 1999-10-21 PL PL347574A patent/PL198827B1/pl not_active IP Right Cessation
- 1999-10-21 AU AU11530/00A patent/AU757602B2/en not_active Ceased
- 1999-11-04 AR ARP990105584A patent/AR021086A1/es active IP Right Grant
- 1999-11-05 US US09/434,107 patent/US6201130B1/en not_active Expired - Lifetime
-
2000
- 2000-12-28 US US09/749,034 patent/US6335333B1/en not_active Expired - Lifetime
-
2001
- 2001-04-30 ZA ZA200103485A patent/ZA200103485B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU757602B2 (en) | 2003-02-27 |
| DK1124797T3 (da) | 2004-07-05 |
| ES2213405T3 (es) | 2004-08-16 |
| EP1124797A1 (de) | 2001-08-22 |
| ZA200103485B (en) | 2001-12-04 |
| JP2002529447A (ja) | 2002-09-10 |
| DE59908769D1 (de) | 2004-04-08 |
| CA2350031C (en) | 2010-01-26 |
| AU1153000A (en) | 2000-05-29 |
| KR100655632B1 (ko) | 2006-12-12 |
| JP4348014B2 (ja) | 2009-10-21 |
| HUP0104122A3 (en) | 2002-04-29 |
| RU2228330C2 (ru) | 2004-05-10 |
| PL347574A1 (en) | 2002-04-08 |
| KR20010080385A (ko) | 2001-08-22 |
| PL198827B1 (pl) | 2008-07-31 |
| CZ302291B6 (cs) | 2011-02-09 |
| US6335333B1 (en) | 2002-01-01 |
| US6201130B1 (en) | 2001-03-13 |
| AR021086A1 (es) | 2002-06-12 |
| TR200101245T2 (tr) | 2001-10-22 |
| DE19851184A1 (de) | 2000-05-11 |
| EP1124797B1 (de) | 2004-03-03 |
| CN1332724A (zh) | 2002-01-23 |
| HK1041686A1 (en) | 2002-07-19 |
| BR9915729A (pt) | 2001-10-23 |
| ID28810A (id) | 2001-07-05 |
| CN1206213C (zh) | 2005-06-15 |
| HUP0104122A2 (hu) | 2002-03-28 |
| CA2350031A1 (en) | 2000-05-18 |
| WO2000027808A1 (de) | 2000-05-18 |
| CZ20011506A3 (cs) | 2001-08-15 |
| PT1124797E (pt) | 2004-07-30 |
| ATE260889T1 (de) | 2004-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1280267C (zh) | 磺酰氨基羧酸 | |
| CN1207056C (zh) | 含肽的α-酮酰胺半胱氨酸和丝氨酸蛋白酶抑制剂 | |
| CN1688548A (zh) | 喹啉抗生素中间体的制备方法 | |
| CN1165815A (zh) | 酚化合物及其制备方法 | |
| CN1172672C (zh) | α-酮酰胺多元催化蛋白酶抑制剂 | |
| CN1228083A (zh) | 芳基磺酰氨基异羟肟酸衍生物 | |
| CN1639159A (zh) | N-氨基乙酰基-吡咯烷-2-腈和它们作为ddp-iv抑制剂的用途 | |
| CN1206213C (zh) | N-芳基磺酰氨基酸ω-酰胺 | |
| CN1228772A (zh) | 杂环金属蛋白酶抑制剂 | |
| CN1377879A (zh) | 新的α-氨基酸磺酰基化合物、其制备方法和含有它们的药物组合物 | |
| CN1254337A (zh) | N-羟基4-磺酰基丁酰胺化合物 | |
| CN1037519A (zh) | 杂环酮类 | |
| CN1440395A (zh) | 作为血管破坏剂的colchinol衍生物 | |
| CN1228780A (zh) | 用作基质金属蛋白酶抑制剂的次膦酸酰胺 | |
| CN1279674A (zh) | 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 | |
| CN1387517A (zh) | 作为环加氧酶-2抑制剂的5-芳基-1h-1,2,4-三唑化合物及含有它们的药物组合物 | |
| CN1230177A (zh) | 作为基质金属蛋白酶抑制剂的β-磺酰基异羟肟酸 | |
| CN1055537A (zh) | 3,5-双取代-2-异唑烷和异唑、其制备方法,含有该成分的制剂及其应用 | |
| CN1180358A (zh) | 作为基质金属蛋白酶抑制剂的桥式吲哚 | |
| CN1132511A (zh) | 基质金属蛋白酶抑制剂 | |
| CN1209368C (zh) | 新的乙酰胺衍生物及其用途 | |
| CN1291993A (zh) | 用作半胱氨酸活性依赖性酶抑制剂的噻二唑化合物 | |
| CN1425004A (zh) | 含杂环侧链的n-取代的金属蛋白酶抑制剂 | |
| CN1418210A (zh) | 含有碳环侧链的n-取代金属蛋白酶抑制剂 | |
| CN1194978C (zh) | 用作药物的次膦酸和膦酸衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20111021 |